PHE Paper Selected As Value in Health Editor's Choice Article

We are proud to announce that a recently published paper with PHE co-authors, “Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations,” has been selected to be an Editors’ Choice article in the June 2017 issue of Value in Health.

To see the complete article as it appears online, please click here.

FEATURED NEWS

Upcoming Live Webinar with Dr. Anupam Jena: What Do Value Assessments Miss?

Please join us on Wednesday, March 13th at 1:30pm EDT for a special, live webinar led by Dr. Anupam Jena, MD, PhD: What Do Value Assessments Miss: Rethinking Value Using New Health Economics EvidenceIn this unique one-hour webinar, Dr. Jena will outline a broader framework for assessing value to improve identification of not only the highest-value treatments, but also low-value therapies on which spending can safely be reduced.

PHE Paper Selected As Value in Health Editor's Choice Article

FEATURED NEWS

Upcoming Live Webinar with Dr. Anupam Jena: What Do Value Assessments Miss?

RELATED ITEMS

Precision’s Schafer and Shafrin Contribute to PharmaLive’s Special Feature on Value

Jason Shafrin comments on ICER's announcement to examine unsupported price increases

Chou Outlines Key Challenges in US Biosimilars Marketplace in STAT News

JCP Summarizes Baumgardner Study on CAR-T Treatment Cost-Effectiveness

PHE’s Shafrin Provides Perspective on Part B Flat Rate Drug Proposal

RECENT NEWS

Precision’s Jansen to Lead ISPOR Summit Series Workshop on New Approaches to Value Assessment

PHE Researchers Study ICER Budget Impact Models in New Study

Baumgardner Discusses OCM Research on AJMC's Podcast